Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children-Reference-Cited by-同舟云学术

Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children

Published:2020-11 Issue: Volume:139 Page:135-148
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Pearson Andrew DJ.^ORCID,Stegmaier Kimberly,Bourdeaut Franck,Reaman Gregory,Heenen Delphine,Meyers Michael L.,Armstrong Scott A.,Brown Patrick^ORCID,De Carvalho Daniel^ORCID,Jabado Nada,Marshall Lynley,Rivera Miguel,Smith Malcolm,Adamson Peter C.,Barone Amy,Baumann Christian,Blackman Samuel,Buenger Vickie,Donoghue Martha,Duncan Aundrietta D.,Fox Elizabeth,Gadbaw Brian,Hattersley Maureen,Ho Peter,Jacobs Ira,Kelly Michael J.,Kieran Mark^ORCID,Lesa Giovanni,Ligas Franca,Ludwinski Donna,McDonough Joe,Nikolova Zariana,Norga Koen,Senderowicz Adrian,Taube Tilmann,Weiner Susan,Karres Dominik,Vassal Gilles

Funder

Alex's Lemonade Stand Foundation for Childhood Cancer

Andrew McDonough B+ Foundation

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference113 articles.

1. Creating a unique, multi-stakeholder Paediatric Oncology Platform to improve drug development for children and adolescents with cancer;Vassal;Eur J Canc,2015

2. ACCELERATE and European Medicine Agency Paediatric Strategy Forum for medicinal product development for mature B-cell malignancies in children;Pearson;Eur J Canc,2019

3. ACCELERATE and European medicines agency paediatric strategy Forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients;Pearson;Eur J Canc,2020

4. Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents;Pearson;Eur J Canc,2020

5. Chromatin regulatory mechanisms and therapeutic opportunities in cancer;Valencia;Nat Cell Biol,2019

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer;European Journal of Cancer;2024-08

2. Navigating Treatment Options and Communication in Relapsed Pediatric AML;American Society of Clinical Oncology Educational Book;2024-06

3. Pediatric oncology drug development and dosage optimization;Frontiers in Oncology;2024-01-29

4. Policy of pediatric oncology drug development;Essentials of Translational Pediatric Drug Development;2024

5. Impact of ACCELERATE Paediatric Strategy Forums: a review of the value of multi-stakeholder meetings in oncology drug development;JNCI: Journal of the National Cancer Institute;2023-11-17